Effectiveness and Limitations of β-Blocker Therapy in Congenital Long-QT Syndrome

2000836 citationsJournal Articlebronze Open Access

Authors

Arthur J. Moss · University of Pavia

Wojciech Zaręba · Fondazione Salvatore Maugeri

William J. Hall · Istituti di Ricovero e Cura a Carattere Scientifico

Peter J. Schwartz · University of Pavia

Richard S. Crampton · University of Virginia

Jesaia Benhorin · University of Pavia

G. Michael Vincent

Abstract

beta-blockers are associated with a significant reduction in cardiac events in LQTS patients. However, syncope, aborted cardiac arrest, and LQTS-related death continue to occur while patients are on prescribed beta-blockers, particularly in those who were symptomatic before starting this therapy.

Topics & Keywords

Cardiac electrophysiology and arrhythmias Cardiac Arrhythmias and Treatments ECG Monitoring and Analysis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation

Volume 101, Issue 6, pp. 616-623

DOI: 10.1161/01.cir.101.6.616

Field-Weighted Citation Impact: 31.59